Association between Her2/neu expression and hormon receptor status in breast cancer patients.
Journal
Acta clinica Croatica
Date Issued
2002-06
Author(s)
Yashar, Genghis
Kraleva, Slavica
Vasev, Nikola
Ivkovski, Ljube
Prodanova, Irina
Kubelka, Katerina
Zografski, George
Abstract
Determination of HER2/neu expression by immunohistochemistry is mandatory for application of Herceptin® therapy in breast cancer patients. The purpose of this study was to investigate the association between HER2/neu expression and hormone receptor status, as well as with other clinicopathological parameters in breast cancer patients. HER2/neu, p53 and Ki-67 expression was determined in 169 postoperative stage I-III (UICC, 1997) breast cancer patients using the standardized DAKO HercepsTest® and immunoperoxidase technique, respectively. The results of HER2/neu immunoreactivity were evaluated by performing the standardized scoring system (0 = negative, 1+ = weakly positive, 2+ = positive, 3+ = strongly positive staining), while ER and PgR were scored in a semiquantitative fashion (ER-ICA and PR-ICA). The results from HER2/neu expression were correlated to hormonal receptor status and clinicopathological parameters (tumor size, histopathologic grade, nuclear grade, histologic type of the tumor, lymph node status and patient age). Statistical significance was determined with χ2 and Fisher’s exact test. HER2/neu expression was positive in 66 patients (37%). There was no significant association between the values of HER2/neu and ER/PgR status, or with any other clinicopathological parameter. ER status significantly correlated with PgR status (p<0.01), tumor size (p<0.01), lymph-node involvement (p<0.01) and tumor type (p<0.01). PgR status was related to the histopathologic grade (p<0.01), lymph-node status (p<0.01), tumor type (p<0.01) and patient age (p<0.01). HER2/neu is a relatively new promising marker in predicting the response to target specific therapy. However, its predictive value remains a complex and inconclusive subject. According to our results, the prognostic potential of HER2/neu seems to be independent from hormone receptor status and any other clinicopathological parameter in breast cancer patients.
File(s)![Thumbnail Image]()
![Thumbnail Image]()
Loading...
Name
Acta Clin Croatica pp161.pdf
Size
751.98 KB
Format
Adobe PDF
Checksum
(MD5):9f7cfe256babca00921ae433b78332f9
Loading...
Name
Acta clin Croatica 2002 cover.pdf
Size
215.69 KB
Format
Adobe PDF
Checksum
(MD5):9a2559d78d9fdb08e65725f77e47dac2